REFERENCES
1. Fechine COC, Valente NYS, Romiti R. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features. An Bras Dermatol. 2022;97(3):348-357. doi:10.1016/j.abd.2021.08.008
2. Ghosh A, Coondoo A. Lichen planus pigmentosus: the controversial consensus. Indian J Dermatol. 2016;61(5):482-6. doi:10.4103/0019-5154.190108
3. Mulinari-Brenner FA, Guilherme MR, Peretti MC, et al. Frontal fibrosing alopecia and lichen planus pigmentosus: diagnosis and therapeutic challenge. An Bras Dermatol. 2017;92(5 Suppl 1):79-81. doi:10.1590/abd1806-4841.20175833
4. Dlova NC. Frontal fibrosing alopecia and lichen planus pigmentosus: is there a link? Br J Dermatol. 2013;168(2):439-42. doi:10.1111/j.1365-2133.2012.11146.x
5. Xavier de Brito FO, Cortez de Almeida RF, Machado CJ, et al. Frontal fibrosing alopecia associated with lichen planus pigmentosus: A multicentre retrospective descriptive analytical study of 104 patients. J Eur Acad Dermatol Venereol. 2023;doi:10.1111/jdv.19093
6. Pirmez R, Duque-Estrada B, Donati A, et al. Clinical and dermoscopic features of lichen planus pigmentosus in 37 patients with frontal fibrosing alopecia. Br J Dermatol. 2016;175(6):1387-1390. doi:10.1111/bjd.14722
7. Romiti R, Biancardi Gavioli CF, Anzai A, et al. Clinical and histopathological findings of frontal fibrosing alopecia-associated lichen planus pigmentosus. Skin Appendage Disord. 2017;3(2):59-63. doi:10.1159/000456038
8. Miteva M, Whiting D, Harries M, et al. Frontal fibrosing alopecia in black patients. Br J Dermatol. Jul 2012;167(1):208-10. doi:10.1111/j.1365-2133.2012.10809.x
9. Cappetta ME, Alvarez G, Noguera M, et al. Frontal fibrosing alopecia associated with lichen planus pigmentosus: not only in dark phototypes. Skin Appendage Disord. Jul 2020;6(4):235-239. doi:10.1159/000507379
10. Berliner JG, McCalmont TH, Price VH, et al. Frontal fibrosing alopecia and lichen planus pigmentosus. J Am Acad Dermatol. 2014;71(1):e26-7. doi:10.1016/j. jaad.2013.12.031
11. Tavakolpour S, Mahmoudi H, Abedini R, et al. Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment. Int J Womens Dermatol. 2019;5(2):116-123. doi:10.1016/j.ijwd.2018.11.003
12. Miao YJ, Jing J, Du XF, et al. Frontal fibrosing alopecia: A review of disease pathogenesis. Front Med (Lausanne). 2022;9:911944. doi:10.3389/ fmed.2022.911944
13. Iorizzo M, Tosti A. Frontal fibrosing alopecia: an update on pathogenesis, diagnosis, and treatment. Am J Clin Dermatol. 2019;20(3):379-390. doi:10.1007/s40257-019- 00424-y
14. Ho A, Shapiro J. Medical therapy for frontal fibrosing alopecia: A review and clinical approach. J Am Acad Dermatol. 2019;81(2):568-580. doi:10.1016/j.jaad.2019.03.079
15. Robles-Mendez JC, Rizo-Frias P, Herz-Ruelas ME, et al. Lichen planus pigmentosus and its variants: review and update. Int J Dermatol. 2018;57(5):505-514. doi:10.1111/ ijd.13806
16. Heppt MV, Letule V, Laniauskaite I, et al. Frontal fibrosing alopecia: a retrospective analysis of 72 patients from a German academic center. Facial Plast Surg. 2018;34(1):88-94. doi:10.1055/s-0037-1615281
17. Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol. 1997;36(1):59-66. doi:10.1016/ s0190-9622(97)70326-8
18. Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 2014;70(4):670-678. doi:10.1016/j.jaad.2013.12.003
19. Donovan JC. Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia. JAAD Case Rep. 2015;1(6):353-5. doi:10.1016/j. jdcr.2015.08.003
20. Rakowska A, Gradzinska A, Olszewska M, et al. Efficacy of isotretinoin and acitretin in treatment of frontal fibrosing alopecia: retrospective analysis of 54 cases. J Drugs Dermatol. Oct 01 2017;16(10):988-992.
21. Syder N, Sicco K, Gutierrez D. Updates In Therapeutics for Lichen Planus Pigmentosus. J Drugs Dermatol. 2022;21(3):324-330. doi:10.36849/JDD.6454
22. Al-Mutairi N, El-Khalawany M. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol. 2010;24(5):535-40. doi:10.1111/j.1468-3083.2009.03460.x
23. Verma P, Pandhi D. Topical tacrolimus and oral dapsone combination regimen in lichen planus pigmentosus. Skinmed. 2015;13(5):351-4.
24. Zenjari L, Elfetoiki FZ, Hali F, et al. Oral tranexamic acid in the treatment of lichen planus pigmentosus: A prospective study of 20 cases. Ann Dermatol Venereol. 2020;147(12):818-822. doi:10.1016/j.annder.2020.06.017
25. Muthu SK, Narang T, Saikia UN, et al. Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study. Int J Dermatol. Sep 2016;55(9):1048-54. doi:10.1111/ijd.13293
26. Bhutani LK, George M, Bhate SM. Vitamin A in the treatment of lichen planus pigmentosus. Br J Dermatol. 1979;100(4):473-4. doi:10.1111/j.1365-2133.1979. tb01653.x
27. Bhari N, Sharma VK, Singh S, et al. Effect of Q-switched Nd-YAG laser on the clinical, pigmentary, and immunological markers in patients with lichen planus pigmentosus: A pilot study. Dermatol Ther. 2020;33(2):e13208. doi:10.1111/dth.13208
28. Sonthalia S, Vedamurthy M, Thomas M, et al. Modified phenol peels for treatment-refractory hyperpigmentation of lichen planus pigmentosus: A retrospective clinico-dermoscopic analysis. J Cosmet Dermatol. 2019;18(5):1479-1486. doi:10.1111/ jocd.12862
29. Sindhura KB, Vinay K, Kumaran MS, et al. Lichen planus pigmentosus: a retrospective clinico-epidemiologic study with emphasis on the rare follicular variant. J Eur Acad Dermatol Venereol. 2016;30(11):e142-e144. doi:10.1111/jdv.13454